Effect of sulpiride on the amphetamine-induced changes in extracellular dopamine, DOPAC, and hydroxyl radical generation in the rat striatum

Neurochemical Research

Volumn 28, Issue 8, 2003, Pages 1241-1248

  Anderzhanova, Elmira ^a   Rayevsky, Kirill S ^a   Saransaari, Pirjo ^d   Oja, Simo S ^b,c  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d NONE

Author keywords

D Amphetamine; Hydroxyl radicals; Microdialysis; Neurotoxicity; Striatum; Sulpiride

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DEXAMPHETAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; HYDROXYL RADICAL; PSYCHOSTIMULANT AGENT; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; MALE; MICRODIALYSIS; NERVE INJURY; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; STEREOTYPY;

3,4-DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; HYDROXYL RADICAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SULPIRIDE;

ANIMALIA;

EID: 0038724132     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024240814923     Document Type: Article

References (62)

1. Fibiger, H. C. and McGeer, E. G. 1971. Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. Eur. J. Pharmacol. 16: 176-180.
2. Hotchkiss, A. J. and Gibb, J. W. 1980. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214:257-262.
3. Ricaurte, G. A., Guillery, R. W., Seiden, L. S., Schuster, C. R., and Moore, R. Y. 1982. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235:93-103.
4. Nakayama, M., Loyama, T., and Yamashita, I. 1992. Long lasting decreases in dopamine uptake rates following repeated administration of methamphetamine in rat striatum. Brain Res. 601:209-212.
5. Afanas'ev, I. I., Anderzhanova, E. A., Kudrin, V. S., and Rayevsky, K. S. 2001. Effects of amphetamine and sydnocarb on dopamine release and free radical generation in rat striatum. Pharmacol. Biochem. Behav. 69:653-658.
6. LaVoie, M. J. and Hastings, T. G. 1999. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine. J. Neurosci. 19:1484-1491.
7. Stokes, A. H., Hastings, T. G., and Vrana, K. E. 1999. Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55:659-665.
8. Yamamoto, B. K. and Zhu, W. 1998. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287:107-114.
9. Abekawa, T., Ohmori, T., and Koyama, T. 1994. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus. Brain Res. 643:276-281.
10. Cadet, J.-L. and Brannock, C. 1998. Free radicals and the pathology of the brain dopamine systems. Neurochem. Int. 32:117-131.
11. Stephans, S. and Yamamoto, B. K. 1994. Methamphetamine- induced neurotoxicity: Role for glutamate and dopamine efflux. Synapse 17:203-209.
12. 1 receptor agonists and antagonists. J. Neurochem. 48:824-831.
13. Miroshnichenko, I. I., Kudrin, V. S., and Rayevsky, K. S. 1988. Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats. Farmakol. Toksikol. 4:26-29.
14. Sharp, T., Zetterstrom, T., Ljungberg, T., and Ungerstedt, U. 1986. Effect of sulpiride on the amphetamine-induced behavior in relation to changes in striatal dopamine release in vivo. Eur. J. Pharmacol. 129:411-415.
15. Albers, D. S. and Sonsalla, P. K. 1995. Methamphetamine induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and non-protective agents. J. Pharmacol. Exp. Ther. 275:1104-1114.
16. 3H]sulpiride. Eur. J. Pharmacol. 138:61-68.
17. Morari, M., Marti, M., Sbrenna, S., Fuxe, K., Bianchi, C., and Beani, L. 1998. Reciprocal dopamine-glutamate modulation of release in basal ganglia. Neurochem. Int. 33:383-397.
18. Frost, D. O. and Cadet, J.-L. 2000. Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: A hypothesis. Brain Res. Rev. 34:103-118.
19. Tapia, R., Medina-Ceja, L., and Peña, F. 1999. On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration in vivo. Neurochem. Int. 34:23-31.
20. Paxinos, G. and Watson, C. 1986. The rat brain in stereotaxic coordinates. (2nd ed.) Academic Press, Sydney.
21. Kroph, W. and Kuschinsky, K. 1993. Conditioned effects of apomorphine are manifested in regional EEG of rats both in hippocampus and in striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:487-493.
22. Havemann, U., Magnus, B., Moller, H. G., and Kuschinsky, K. 1986. Individual and morphological differences in the behavioural response to apomorphine in rats. Psychopharmacologia 90:40-48.
23. Anderzhanova, E. A., Afanas'ev, I. I., Kudrin, V. S., and Rayevsky, K. S. 2000. Effect of D-amphetamine and sydnocarb on the extracellular level of dopamine, 3,4-dihydrophenylacetic acid and hydroxyl radical generation in rat striatum. Ann. NY Acad. Sci. 914:137-145.
24. Moore, S. and Kenyon, P. 1994. Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion. Psychopharmacologia 114:123-130.
25. Rebec, G. V. and Bashore, T. R. 1984. Critical issues in assessing the behavioural effects of amphetamine. Neurosci. Biobehav. Rev. 8:153-159.
26. Lyon, M. and Robbins, T. 1975. The action of central nervous system stimulant drugs: A general theory concerning amphetamine effects. Pages 79-163, in Essman, W. B. and Valzelli, L. (eds.), Current development in psychopharmacology. Spectrum, New York.
27. Wallace, T. L., Gudelsky, G. A., and Vorhees, C. V. 1999. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behaviour, and stimulated dopamine release in the rat. J. Neurosci. 19:9141-9148.
28. Graham, D. G., Tiffany, S. M., Bell, W. B., and Gutknecht, W. F. 1978. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxy dopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:644-653.
29. McLaughlin, B. A., Nelson, D., Erecińska, M., and Cheslet, M. F. 1998. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem. 70:2406-2415.
30. Hastings, T. G., Lewis, D. A., and Zigmond, M. J. 1996. Role of oxidation in the neurotoxic effects in intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93:1956-1961.
31. Devito, M. J. and Wagner, G. C. 1989. Methamphetamine- induced neuronal damage: A possible role for free radicals. Neuropharmacology 28:1145-1150.
32. Shankaran, M., Yamamoto, B. K., and Gudelsky, G. A. 2001. Ascorbic acid prevents 3,4-methylenedioxyamphetamine (MDMA) induced hydroxyl radical formation and the behavioural and neurochemical consequences of the depletion of brain 5-HT. Synapse 40:55-64.
33. Wagner, G. C., Carelli, R. M., and Jarvis, M. F. 1985. Pretreatment with ascorbic acid attenuate the neurotoxic effects of methamphetamine in rats. Res. Commun. Chem. Path. Pharmacol. 47:221-228.
34. Gibb, J. W. and Kogan, F. J. 1979. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedeberg's Arch. Pharmacol. 310:185-187.
35. Jonson, M., Stone, D. M., Hanson, G. R., and Gibb, J. W. 1987. Role of dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur. J. Pharmacol. 135:231-234.
36. Schmidt, C. J., Ritter, J. K., Sonsalla, P. K., Hanson, G. R., and Gibb, J. W. 1985. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233:539-544.
37. O'Dell, S. J., Weihmuller, F. B., and Marshall, J. F. 1991. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine, which correlate with subsequent neurotoxicity. Brain Res. 564:256-260.
38. Fumagalli, F., Gainetdinov, R. R., Wang, Y. M., Valenzano, K. J., Miller, G. W., and Caron, M. G. 1999. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J. Neurosci. 19:2424-2431.
39. Miller, G. W., Gainetdinov, R. R., Levey, A. I., and Caron, M. G. 1999. Dopamine transporters and neuronal injury. Trends Pharmacol. Sci. 20:424-429.
40. Fleckenstein, A. E., Gibb, J. W., and Hanson, G. R. 2000. Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implication for neurotoxicity. Eur. J. Pharmacol. 406:1-13.
41. 2 antagonists. J. Neurochem. 60:1792-1799.
42. O'Dell, S. J., Weihmuller, F. B., McPherson, R. J., and Marshall, J. F. 1994. Excitotoxic striatal lesion protects against subsequent neurotoxicity. J. Pharmacol. Exp. Ther. 269:1319- 1325.
43. Burrows, K. B., Gudelsky, G., and Yamamoto, B. K. 2000. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur. J. Pharmacol. 398:11-18.
44. Nash, J. F. and Yamamoto, B. K. 1992. Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3.4-methylenedioxymethamphetamine. Brain Res. 581:237-243.
45. 1 dopamine receptor antagonists produce biphasic effects on glutamate efflux in rat ventral tegmentum area: Modification by repeated amphetamine administration. J. Neurochem. 70:198-209.
46. Abarca, J. and Bustos, G. 1999. Differential regulation of glutamate, aspartate and γ-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway. Neurochem. Int. 35:19-33.
47. Cepeda, C. and Levin, M. S. 1998. Dopamine and N-methylD-aspartate interaction on neostriatum. Dev. Neurosci. 20:1-18.
48. Yamamoto, B. K. and Davy, S. 1992. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem. 58:1736-1742.
49. Ilyin, V. I., Whittemore, E. R., Guastella, J., Weber, E., and Woodward, R. M. 1996. Subtype-selective inhibition of N- methyl-D-aspartate receptors by haloperidol. Mol. Pharmacol. 50:1541-1550.
50. Lynch, D. R. and Gallagher, M. J. 1996. Inhibition of N-methyl-D-aspartate receptors by haloperidol, developmental and pharmacological characterisation in native and recombinant receptors. J. Pharmacol. Exp. Ther. 279:154-161.
51. Garside, S., Furtado, J. C., and Mazurec, M. F. 1996. Dopamine-glutamate interactions in the striatum: Behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms. Neuroscience 75:1065-1074.
52. Askew, B. M. 1962. Hyperpyrexia as a contributing factor in the toxicity of amphetamine in aggregated mice. Br. J. Pharmacol. 19:245-257.
53. Bowyer, J. F., Tank, A. W., Newport, G. D., Slikker, W. Jr., Ali, S. F., and Holson, R. R. 1992. The influence of environmental temperature on the transient effects of amphetamine on dopamine levels and dopamine release in the rat striatum. J. Pharmacol. Exp. Ther. 260:817-824.
54. Huether, G., Zhou, D., and Ruther, E. 1997. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") and its congeners. J. Neural Transm. 104:771-794.
55. Malberg, J. E. and Seiden, L. S. 1998. Small changes in ambient temperature cause large changes in 3,4-methylendioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J. Neurosci. 18:5086-5094.
56. Nowak, T. S. Jr. 1988. Effects of amphetamine on protein synthesis and energy metabolism in mouse brain: Role of drug-induced hyperthermia. J. Neurochem. 50:285-294.
57. Wolf, M. E., Xue, C.-J., Li, Y., and Wavak, D. 2000. Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species. J. Neurochem. 75:1634-1644.
58. 3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine. Eur. J. Pharmacol. 418:201-206.
59. Crass, W. A. and Gerhard, G. A. 1994. Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176:259-263.
60. 2 receptors may modulate the function of the striatal transporter for dopamine: Kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61:764-767.
61. 2 antagonist pimozidine inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J. Neurochem. 60:376-379.
62. Ferger, B., van Amsterdam, C., Seyfried, C., and Kuschensky, K. 1998. Effects of α-phenyl-tret-butylnitrone and selegrine on hydroxyl free radicals in rat striatum produced by local application of glutamate. J. Neurochem. 70:276-280.